期刊文献+

RNA干扰血管内皮生长因子受体2基因表达提高结肠癌细胞对奥沙利铂敏感性的研究 被引量:1

Study on the sensitivity of colon cancer cells for Oxaliplatin enhanced by RNA interference in the expression of vascular endothelial growth factor receptor-2
下载PDF
导出
摘要 目的研究RNA干扰血管内皮生长因子受体2(VEGFR-2)基因表达对人结肠癌细胞生长的抑制作用和对奥沙利铂的化疗增敏作用。方法构建靶向VEGFR-2基因的小分子干扰RNA(siRNA)表达质粒并转染人结肠癌细胞株SW480;通过RT-PCR和Western blot方法检测VEGFR-2 siRNA对人结肠癌细胞株SW480 VEGFR-2mRNA和蛋白表达的影响;采用MTT实验和流式细胞术检测该siRNA及协同奥沙利铂对细胞增殖及凋亡的影响。结果 VEGFR-2 siRNA显著下调结肠癌细胞VEGFR-2 mRNA和蛋白的表达(P<0.05)。VEGFR-2 siRNA协同奥沙利铂使结肠癌细胞的生长变得更加缓慢,增殖受到明显抑制,细胞抑制及凋亡明显增强(P<0.05)。结论RNA干扰VEGFR-2基因表达可以抑制人结肠癌细胞株SW480的增殖,促进其凋亡,并能提高结肠癌细胞对奥沙利铂的敏感性。 Objective To study the inhibitory effect of RNA interference in the expression of vascular endothelial growth factor receptor-2(VEGFR-2) for the growth of human colon cancer cells and the chemosensitive effect of Oxaliplatin.Methods The expression plasmid of small interferon RNA(si RNA) targeting VEGFR-2 gene was constructed and human colon cancer cell line SW480 was transfected. The effect of VEGFR-2 si RNA for the expression of human colon cancer cells SW480 VEGFR-2 m RNA and protein was detected by RT-PCR and Western blot. The effect of si RNA or combining with Oxaliplatin for the cell proliferation and apoptosis was detected by MTT assay and flow cytometry. Results The m RNA and protein expression of VEGFR-2 were significantly down-regulated by VEGFR-2 si RNA(P 0.05). The combination of VEGFR-2 si RNA and Oxaliplatin could slowdown the growth of colon cancer cells, inhibit the proliferation, and significantly increase the inhibition of cell proliferation and apoptosis(P 0.05). Conclusion Silencing VEGFR-2gene by the si RNA technology can inhibit the proliferation of SW480 cells, induce the apoptosis of SW480 cell, and enhance the chemotherapy sensitivity of Oxaliplatin for human colon cancer cells.
出处 《中国医药导报》 CAS 2017年第20期16-19,共4页 China Medical Herald
基金 国家自然科学基金资助项目(81272556) 广东省省级科技计划项目(2014A020212614) 广东省广州市科技惠民专项项目(2014Y2-00137)
关键词 结肠癌 血管内皮生长因子受体2 小分子干扰RNA 奥沙利铂 Colon cancer Vascular endothelial growth factor receptor-2 Small interferon RNA Oxaliplatin
  • 相关文献

参考文献5

二级参考文献80

  • 1陈递林,彭芝兰,王和,姚先莹.卵巢浆液性肿瘤中的血管生成研究[J].医学研究通讯,2005,34(8):16-18. 被引量:5
  • 2向欣,黄正松,石忠松,夏之柏,胡斌,廖冰.脑星形细胞瘤Livin基因表达与细胞增殖的关系[J].中华实验外科杂志,2005,22(9):1141-1141. 被引量:15
  • 3李文锦,颜士杰,钱和年,张香云,王建六,李小平,宋和存,贾鉴慧,林文玉.卵巢粘液性囊腺癌EGFR、neu、PCNA的表达与临床病理研究[J].浙江肿瘤,1996,2(2):67-69. 被引量:3
  • 4徐建明,李月敏,王岩,赵传华,袁守军,杨武威,李志强,韩宇,AmaliaAzzariti,AngeloParadiso.表皮生长因子受体酪氨酸激酶抑制剂ZD1839与伊利替康联合效应的实验研究[J].中华肿瘤杂志,2006,28(8):578-582. 被引量:4
  • 5Darai E, Bringuier AF, Walker-Combrouze F, et al. CD31 expression in beingn,borderline, and malignant epithelial ovarian tumor: an immunohistochemical and serological analysis. Gynecol Oncol, 1998, 71:122-127.
  • 6Brinkhuis M, Izquierdo MA, Baak JP, et al. Expression of multidmg resistance-associated markers, their relation to quantitative pathologic tumor characteristics and prognosis in advanced ovarian cancer. Anal Cell Pathol, 2002, 24 : 17-23.
  • 7Izquierdo MA, van der Zee AG, Vermorken JB, et al. Drug resistanceassociated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst, 1995, 87 : 1230-1237.
  • 8Arts HJ, Katsaros D, de Vries EG, et al. Drug resistance-asscciated markers P-glycoprotein, muhidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clin Cancer Res, 1999, 5:2798-2805.
  • 9Tomov S, Popovska S, Veselinova T, et al. Immunohistoehemical analysis of epidermal growth factor receptors expression in malignant ovarian tumors. Akush Ginekol (Sofiia), 2005,44 Suppl 2:42-47.
  • 10Kolfschoten GM, Hulscher TM, Pinedo HM, et al. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts. Br J Cancer, 2000, 83:921-927.

共引文献62

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部